Projects in the pipeline
These are some of the projects that we are currently working on. Contact us on to find out more about these projects.
Women in healthcare and the life sciences: Yesterday, today and tomorrow
From the start of the modern biotechnology era women have been involved in many of its ground-breaking medical discoveries. Yet, despite their importance, the story of these pioneering female scientists has been largely overshadowed by those of the male colleagues. To address this gap we at WhatIsBiotechnology are developing a public engagement platform to champion the contribution women have made and continue to make to the life sciences and their applications in medicine. The aim is to encourage young female scientists who will be the leaders of tomorrow to pursue careers in research and education related to drug discovery.
One of the key elements of the platform will be an online digital exhibition designed to explore the numerous roles women have played and continue to play in the life sciences and its application to healthcare. Using historical documents, photos, and material gathered through interviews, the exhibition will be used to initiate a conversation between female scientists, bio-entrepreneurs, young women and other key stakeholders about the challenges and rewards women have historically faced and continue to experience in the area. Click here to find out more about this project.
Anticipated launch early-mid 2018.
Conquering Hepatitis B: A revolution for public health and vaccine safety
More infectious than HIV, the hepatitis B virus (HBV) is one of the most common causes of liver cancer and cirrhosis. The only thing that can break the cycle of hepatitis B infection is the HBV vaccine. First introduced in the early 1980s, the HBV vaccine has been one of the most successful biotechnology innovations in medicine. Helping to significantly reduce the global incidence of hepatitis B, the HBV vaccine was the first vaccine to prevent cancer. In addition the techniques pioneered in making the vaccine greatly enhanced the safety and efficacy of vaccines overall.
Despite these achievements, hepatitis B remains a major public health burden. One of critical challenges today is getting people to understand the importance of immunisation with the vaccine given the hidden nature of the disease and ignorance of just how easily the virus is spread by exposure to infected blood. To address this gap in public knowledge, WhatIsBiotechnology is developing a public engagement project around hepatitis B and its vaccine together with collaborators. To find out more about the hepatitis B project click here.
Anticipated launch second quarter 2018.
Immunotherapy and the changing landscape of cancer
Immunotherapy has been hailed as one of the most promising avenues for cancer treatment today. Now that cancer immunotherapy is proving successful in the treatment of some hard-to-treat cancers, it is easy to forget that mobilising the immune system to attack tumours has not been straightforward and many challenges remain before such treatment can be rolled out on a significant scale.
WhatisBiotechnology is developing a public engagement project to foster a greater understanding about cancer immunotherapy. The aim is to open up a conversation about some of the complexities behind cancer immunotherapy by telling the story of the many scientists, clinicians and patients who have been involved in its development. This will be done through an online digital exhibition and public engagement activities.
Anticipated launch third quarter 2018.